| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | Voliotis Dimitris | SVP, Clinical Development | Feb 14, 2022 | Sale | $50.23 | 601 | 30,188 | 16,045 | Feb 14, 2022, 09:10 PM | |
| ZNTL | Zentalis Pharmaceuticals, Inc. | Voliotis Dimitris | SVP, Clinical Development | Jan 19, 2022 | Option Exercise | $18.00 | 10,000 | 180,000 | 16,250 | Jan 20, 2022, 07:15 PM | |
| ZNTL | Zentalis Pharmaceuticals, Inc. | Voliotis Dimitris | SVP, Clinical Development | Jan 19, 2022 | Sale | $60.79 | 10,000 | 607,931 | 8,361 | Jan 20, 2022, 07:15 PM | |
| ZNTL | Zentalis Pharmaceuticals, Inc. | Voliotis Dimitris | SVP, Clinical Development | Jan 20, 2022 | Option Exercise | $18.00 | 10,000 | 180,000 | 16,250 | Jan 20, 2022, 07:15 PM | |
| ZNTL | Zentalis Pharmaceuticals, Inc. | Voliotis Dimitris | SVP, Clinical Development | Jan 20, 2022 | Sale | $60.63 | 10,000 | 606,323 | 7,907 | Jan 20, 2022, 07:15 PM | |
| ZNTL | Zentalis Pharmaceuticals, Inc. | Voliotis Dimitris | SVP, Clinical Development | Jan 18, 2022 | Option Exercise | $18.00 | 10,000 | 180,000 | 16,250 | Jan 20, 2022, 07:15 PM | |
| ZNTL | Zentalis Pharmaceuticals, Inc. | Voliotis Dimitris | SVP, Clinical Development | Jan 18, 2022 | Sale | $62.65 | 10,000 | 626,491 | 12,841 | Jan 20, 2022, 07:15 PM |
Menu